Degenerative Disease of the Lumbosacral Spine clinical trials at UC Davis
1 research study open to eligible people
Transforaminal Lumbar Interbody Fusion (TLIF)
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is a global, multi-center, prospective, randomized, blinded, controlled pivotal study. Clinical and radiological evaluation will be performed preoperatively and postoperatively up to 24 months; and endpoint success will be determined at 24 months postoperatively. Overall a maximum of 1017 subjects will be enrolled and treated. The purpose of the study is to provide safety and effectiveness data of Infuse™ in A Transforaminal Lumbar Interbody Fusion (TLIF) procedures and to obtain indication expansion for Infuse™ use in one and two level TLIF procedures.
Sacramento, California and other locations
Our lead scientists for Degenerative Disease of the Lumbosacral Spine research studies include Kee Kim.
Last updated: